ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Meng Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1641-485X; OpenAlex author ID A5077045152. Sources: OpenAlex.

Their work

Papers: 4 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dengfeng Li · 2 shared papers, 2022–2024 · strength 0.41
- Paper Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using … DOI 10.1007/s00330-023-09980-8 ↗
- Paper Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperat… DOI 10.1016/j.ejrad.2022.110313 ↗
Wei Cai · 2 shared papers, 2022–2024 · strength 0.41
- Paper Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using … DOI 10.1007/s00330-023-09980-8 ↗
- Paper Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperat… DOI 10.1016/j.ejrad.2022.110313 ↗
Nan Zhang · 1 shared paper, 2025 · strength 0.30
- Paper Changes in intestinal microbiota in patients with pancreatic cancer: a systematic review and meta-analysis. DOI 10.3389/fmicb.2025.1619323 ↗
Xiaohong Ma · 1 shared paper, 2024 · strength 0.23
- Paper Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using … DOI 10.1007/s00330-023-09980-8 ↗
Xinming Zhao · 1 shared paper, 2024 · strength 0.23
- Paper Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using … DOI 10.1007/s00330-023-09980-8 ↗
Xinming Zhao · 1 shared paper, 2022 · strength 0.19
- Paper Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperat… DOI 10.1016/j.ejrad.2022.110313 ↗
Xu Li · 1 shared paper, 2018 · strength 0.09
- Paper Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production … DOI 10.7150/ijbs.26776 ↗
Xingjun Guo · 1 shared paper, 2018 · strength 0.09
- Paper Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production … DOI 10.7150/ijbs.26776 ↗
Min Wang · 1 shared paper, 2018 · strength 0.09
- Paper Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production … DOI 10.7150/ijbs.26776 ↗
Ruizhi He · 1 shared paper, 2018 · strength 0.09
- Paper Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production … DOI 10.7150/ijbs.26776 ↗
Jianxin Jiang · 1 shared paper, 2018 · strength 0.09
- Paper Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production … DOI 10.7150/ijbs.26776 ↗
Renyi Qin · 1 shared paper, 2018 · strength 0.09
- Paper Combined inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production … DOI 10.7150/ijbs.26776 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.